Off FDA’s Hook, India’s Claris Moves To Link Up Again With Pfizer, But Falters
This article was originally published in The Pink Sheet Daily
Executive Summary
Claris has been through grueling times implementing corrections mandated by U.S. FDA and set its sights on reclaiming a valuable supply deal, but Pfizer has distanced itself from the company.